Skip to content
HomeLatest newsHealth & wellnessBy the numbers: Understanding the toll of inflammatory bowel disease
Person with hand on stomach

By the numbers: Understanding the toll of inflammatory bowel disease

For Colitis and Crohn’s Disease Awareness Week, learn about the challenges of this painful condition—and why Johnson & Johnson continues to seek new treatment options.

Living with Crohn’s disease or ulcerative colitis—collectively known as inflammatory bowel disease (IBD)—isn’t easy. Characterized by chronic inflammation of the digestive tract, IBD is an immune-mediated condition that typically causes diarrhea, weight loss, fatigue and abdominal pain.

But the burden of living with IBD goes beyond the physical pain. People with IBD often talk about the shame and embarrassment of having a “bathroom” disease. No surprise, this can lead to mental health problems such as depression and anxiety.

Treatment for people with IBD has improved dramatically in the past 25 years since biologic drugs entered the picture. But a significant portion of patients don’t respond to these medications or find that they eventually stop working. That’s why Johnson & Johnson is committed to developing new remedies, in addition to precision medicine approaches that will help speed up diagnosis and help healthcare providers match patients to the best treatment.

For Colitis and Crohn’s Disease Awareness Week, we’re taking a look at the impact of this painful condition across the globe—and some of the reasons why hope is on the horizon.

Understanding the toll of inflammatory bowel disease infographic

Have an idea to transform care for BIPOC communities living with IBD?

The Johnson & Johnson Innovation Inflammatory Bowel Disease QuickFire Challenge: Innovating for Health Equity is accepting applications.

More from Johnson & Johnson

Meet the medical engineer behind the innovative heart pump that revolutionized cardiac health

Drawing on his fascination with airplane technology, Thorsten Siess, Ph.D., came up with an idea that became the Impella heart pump. Now, 25 years since it entered the market, this groundbreaking device has helped more than 330,000 patients recover from heart injuries.

Reconnecting the meaning of these two simple words: Health&Care

Johnson & Johnson is restoring the true meaning of healthcare by developing advanced treatments and smarter and less invasive solutions for today’s most complex diseases.

What you need to know about Johnson & Johnson’s 2024 third quarter earnings

Check out this infographic breakdown of the company’s third quarter performance, with highlights from its Innovative Medicine and MedTech businesses.